Erythema annulare centrifugum

L12_ERYTH_ANNULCENTRIFUG

erythema infectiosum: usually a benign childhood condition characterized by a classic slapped-cheek appearance (see the image below) and lacy exanthem.It results from infection with human parvovirus (PV) B19, an erythrovirus.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L53.1 Hospital discharge: ICD-9 — 6958B Hospital discharge: ICD-8 — 69591 Cause of death: ICD-10 — L53.1 Cause of death: ICD-9 — 6958B Cause of death: ICD-8 — 69591 2 out of 7 registries used, show all original rules.	64
4. Check minimum number of events None	64
5. Include endpoints None	64
6. Filter based on genotype QC (FinnGen only)	61

Control definitions (FinnGen only)

Control exclude: L12_URTICARIAERYTHEMA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L53
Name in latin: Erythema anulare centrifugum

NAME	L12_ERYTH_ANNULCENTRIFUG
CONTROL_EXCLUDE	L12_URTICARIAERYTHEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L531
HD_ICD_9	6958B
HD_ICD_8	69591
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L531
COD_ICD_9	6958B
COD_ICD_8	69591
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Erythema annulare centrifugum based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	491	327	161
Only index persons	439	297	142
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.00
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	55.65	56.35	53.95
Only index persons	54.82	55.33	53.75

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	61	42	19
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	57.14	55.06	61.74

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
64: Matched controls
640

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L53.1

ICD-10 Finland

Erythema annulare centrifugum

10962.3

84.7

L30.9

ICD-10 Finland

Dermatitis, unspecified

8.3

16.0

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

12.1

12.6

D07AC01

ATC

betamethasone; topical

4.7

8.7

151

D07AC13

ATC

mometasone; topical

4.4

7.9

119

L50.8

ICD-10 Finland

Other urticaria

+∞

6.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768443) Skin Pathology biopsy report

7.15

5.94

1.4

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

186

2.77

3.87

3.3

4.2

20.79

21.26

ng/l

0.03

124

(3022217) INR in Platelet poor plasma by Coagulation assay

233

2.72

3.68

32.9

12.4

1.41

1.24

inr

0.44

(3015736) pH of Urine

215

2.54

3.29

4.2

3.4

—

5.74

—

(40760892) CBC W Ordered Manual Differential panel - Blood

242

2.57

3.28

11.2

6.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

5.55

3.16

1.3

1.1

—

(3026008) Bacteria identified in Urine by Culture

162

2.29

2.60

2.3

2.9

—

(3029937) Albumin [Presence] in Urine by Test strip

138

2.33

2.58

5.6

4.2

0.00

estimate

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

206

2.24

2.54

5.7

4.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

5.39

2.46

2.8

5.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

6.66

2.41

2.4

2.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

3.03

2.35

8.4

3.4

0.20

—

(3021601) Nitrite [Presence] in Urine by Test strip

260

2.14

2.24

7.2

5.3

0.00

estimate

—

(3009261) Glucose [Presence] in Urine by Test strip

260

2.14

2.24

5.4

3.9

0.00

estimate

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

4.00

2.22

2.0

1.3

1.13

1.26

g/l

—

(3035350) Ketones [Presence] in Urine by Test strip

261

2.12

2.21

5.5

3.8

0.00

0.02

estimate

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

190

2.09

2.14

4.9

2.9

—

(3017181) Myelocytes/100 leukocytes in Blood

2.81

2.14

8.5

3.3

1.30

0.69

—

(3022145) Colonoscopy Study observation

2.45

2.13

1.0

1.4

—

(3023368) Bacteria identified in Blood by Culture

124

2.18

2.11

4.9

4.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

4.83

1.98

2.0

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2.56

1.95

5.1

3.9

254.08

237.64

u/l

0.26

(3027945) Reticulocytes/100 erythrocytes in Blood

2.56

1.95

3.8

2.8

1.75

1.59

0.21

(3014007) Fractional oxyhemoglobin in Arterial blood

3.56

1.79

5.8

10.4

95.58

95.14

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

3.56

1.79

2.2

1.3

0.20

0.26

g/l

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

4.07

1.75

1.6

2.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

117

2.03

1.71

3.8

3.6

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

3.78

1.64

10.8

1.5

—

(4200892) Spirometry reversibility

2.62

1.60

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

3.52

1.55

2.8

2.9

—

(3020961) Endomysium IgA Ab [Titer] in Serum

3.04

1.54

1.2

1.0

—

(3018418) pH of Serum or Plasma

164

1.86

1.52

4.7

3.7

7.42

7.39

—

(3000330) Specific gravity of Urine by Test strip

2.90

1.47

6.0

3.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

348

1.85

1.42

6.3

4.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2.77

1.40

5.3

3.8

5.45

5.13

kpa

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2.27

1.37

4.6

7.6

119.11

123.49

g/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2.21

1.37

1.9

1.5

—

(3019060) Gas panel - Arterial blood

2.39

1.30

3.8

5.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

2.39

1.30

1.8

1.5

—

(3045414) Leukocytes [Presence] in Urine

2.76

1.24

1.8

—

(3023520) Reticulocytes [#/volume] in Blood

2.20

1.20

4.3

2.8

83.50

66.15

e9/l

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

230

1.67

1.18

2.6

2.4

—

(4035726) Immunohistochemistry procedure

2.14

1.17

1.9

1.3

—

(40761535) Cells panel - Urine sediment

2.08

1.13

3.8

3.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2.49

1.11

1.8

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.94

1.09

1.8

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.84

1.01

1.9

1.7

—

(3037522) Nuclear Ab [Titer] in Serum

1.84

1.01

1.5

1.3

192.00

760.00

titre

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

421

1.70

0.97

11.1

7.7

81.39

78.44

u/l

0.17

391

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2.26

0.94

2.3

2.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1.98

0.91

5.9

5.5

1.23

mmol/l

—

(40761536) Microorganisms panel - Urine sediment

1.93

0.90

6.8

4.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1.90

0.81

4.7

5.2

1.50

1.53

mmol/l

—

(3013512) EKG study

153

1.55

0.81

4.4

3.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.85

0.81

4.2

4.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.81

0.80

1.6

1.4

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.77

0.79

5.1

5.6

102.22

103.61

mmol/l

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

524

1.80

0.77

5.1

4.8

6.03

5.89

mmol/l

0.36

488

(3041096) Erythrocytes [Presence] in Urine by Automated

149

1.50

0.69

6.2

3.6

—

(36660697) Celiac disease serology panel - Serum

1.66

0.67

1.3

1.1

—

(3003694) ABO and Rh group [Type] in Blood

132

1.51

0.67

1.3

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

207

1.43

0.64

2.3

2.0

83.56

95.05

pmol/l

0.62

105

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.65

0.63

1.3

2.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

518

1.65

0.62

19.3

14.0

14.45

22.52

mg/l

1.66

399

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.84

0.60

1.0

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

508

1.59

0.60

4.7

4.0

1.37

1.28

mmol/l

0.51

470

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.59

0.0

1.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.73

0.58

1.8

1.3

—

(3044889) 12 lead EKG panel

381

1.39

0.54

3.1

3.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.50

0.53

1.5

1.4

—

(3000492) Spirometry study

1.58

0.50

1.1

1.3

—

(3012516) Albumin [Mass/volume] in Urine

158

1.39

0.50

4.8

3.1

9.08

52.76

mg/l

1.69

100

(40758558) Short blood count panel - Blood

140

1.40

0.49

4.8

6.0

—

(40761511) CBC panel - Blood by Automated count

549

1.60

0.46

18.7

12.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

170

1.35

0.45

6.3

3.6

1.51

10.08

mg/mmol

1.61

103

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

181

1.33

0.42

4.5

3.5

28.64

30.34

u/l

0.17

172

(3008898) HLA-B27 [Presence]

0.00

0.41

0.0

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.41

0.0

1.7

—

182.19

—

(3036489) Thrombin time

0.00

0.41

0.0

1.6

—

20.35

—

(3000991) Gas panel - Venous blood

1.46

0.40

8.0

5.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.31

0.31

10.4

6.4

—

(3000494) Fungus identified in Specimen by Culture

1.24

0.28

1.6

1.5

—

(3002256) Pathology report gross observation

1.25

0.27

1.3

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

107

1.27

0.24

1.1

1.3

1.66

11.82

u/ml

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

0.00

0.21

0.0

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

3.80

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.21

0.0

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

0.21

0.0

1.5

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

0.00

0.21

0.0

1.9

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.21

0.0

1.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.21

0.0

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.21

0.0

1.8

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.21

0.0

1.3

—

(3011288) Drugs identified in Urine by Screen method

0.00

0.21

0.0

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.25

0.21

1.2

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

492

0.83

0.19

20.6

13.6

77.93

81.57

ml/min/173m2

0.68

402

(36304419) Bacteria [Presence] in Urine

159

1.18

0.17

3.6

2.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.24

0.17

2.2

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.22

0.16

1.2

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

152

1.16

0.14

2.5

2.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.12

0.10

1.2

1.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.09

0.08

2.0

1.5

—

(40768797) Stomach Pathology biopsy report

1.08

0.08

1.5

1.2

—

(40768804) Tissue Pathology biopsy report

219

1.08

0.05

2.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1.10

0.03

3.5

2.1

12.40

13.17

umol/l

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

109

1.01

0.00

2.5

1.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

316

1.03

0.00

2.9

—

(1761868) Lipid panel - Serum or Plasma

188

1.02

0.00

4.4

2.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

0.96

0.00

1.5

1.9

1.32

1.42

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

-0.00

0.0

1.4

—

(3042936) Bacteria identified in Isolate by Culture

0.95

-0.00

2.0

2.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

-0.00

0.0

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

-0.00

0.0

1.8

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

-0.00

0.0

1.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

4.7

—

15.28

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.6

—

0.33

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

98.89

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

-0.00

0.0

1.6

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

0.95

-0.00

3.9

2.3

2.41

2.42

g/l

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

-0.00

0.0

1.0

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

-0.00

0.0

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

-0.00

0.0

1.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

-0.00

0.0

1.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3005033) Fetal Nuchal fold Thickness US

0.00

-0.00

0.0

1.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

(3023410) Appearance of Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

-0.00

0.0

3.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

-0.00

0.0

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

-0.00

0.0

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

-0.00

0.0

1.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

-0.00

0.0

1.6

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

37.80

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

-0.00

0.0

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3005570) Glucose [Moles/volume] in Urine

0.00

-0.00

0.0

2.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.02

-0.00

2.1

1.5

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

0.88

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

2.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.1

—

(3020491) Glucose [Moles/volume] in Blood

0.00

-0.00

0.0

3.3

—

6.78

—

(3021788) Differential panel - Synovial fluid

0.00

-0.00

0.0

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

1.0

—

118.56

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

16.18

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

2.0

—

4.51

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

-0.00

0.0

1.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

-0.00

0.0

1.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

-0.00

0.0

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

1.56

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_ERYTH_ANNULCENTRIFUG and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_ERYTH_ANNULCENTRIFUG.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_ERYTH_ANNULCENTRIFUG – Erythema annulare centrifugum

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Erythema annulare centrifugum

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints